Trials / Completed
CompletedNCT00818324
Long Term Administration Study of OPC-12759 Ophthalmic Suspension
Long Term Administration Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate safety and efficacy of OPC-12759 ophthalmic suspension during 52 weeks in dry eye patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-12759 Ophthalmic suspension | Instillation,4times/day,for 52weeks |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-09-01
- Completion
- 2011-01-01
- First posted
- 2009-01-07
- Last updated
- 2014-02-26
- Results posted
- 2014-02-26
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00818324. Inclusion in this directory is not an endorsement.